journal article·2023

A fast-acting brain-targeted nano-delivery system with ultra-simple structure for brain emergency poisoning rescue

Yao Li, Zinan Zhang, Jingyi Huang, Huanchun Xing, Lin Wang, Lijuan Huang, Xin Sui, Yuan Luo, Liao Shen, Yongan Wang, Jun Yang

Nanoscale· Volume 15· Issue 10
Publisher page

Abstract

Treatment for acute brain conditions remains a major challenge owing to the unavailability of antidotes, especially for organophosphorus compounds, exposure to which leads to rapid death. Despite recent advances in brain-targeted nano delivery systems (BTNDS), the traditional ones which have been developed will likely not lead to the quick release of an antidote, which is essential to counteract fast neurotoxic effects. Herein, we present a BTNDS using thermosensitive liposomes, without the need for functionalization, to obtain a platform for brain-targeted delivery, which has a simple structure and thus can be easily synthesized and scaled-up. The brain-targeting effect of BTNDS was amplified by phospholipase A2 (PLA2), an inflammatory biomarker. The combination of PLA2 and BTNDS significantly improved brain targeting, leading to an excellent emergency rescue effect - 83- and 4.8-fold better cerebral AChE reactivation response and survival time, respectively. These findings provide a promising strategy to generate a facile, druggable, and effective BTNDS.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Traumatic Brain Injury and Neurovascular Disturbances · Anesthesia and Neurotoxicity Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China

References (47)

Show source-provided references
1. Lapointe · Lancet · 2018 · 392 · 43210.1016/S0140-6736(18)30990-5 ↗
2. Mischel · Nat. Clin. Pract. Neurol. · 2006 · 2 · 23210.1038/ncpneuro0145 ↗
3. Nassan · Nat. Rev. Neurol. · 2021 · 1
4. Voet · EMBO Mol. Med. · 2019 · 11 · 110.15252/emmm.201810248 ↗
5. Shen · Adv. Mater. · 2021 · 33 · 210199310.1002/adma.202101993 ↗
6. Tian · Biomaterials · 2018 · 150 · 13710.1016/j.biomaterials.2017.10.012 ↗
7. Manek · J. Appl. Toxicol. · 2021 · 41 · 2010.1002/jat.4029 ↗
8. Furtado · Adv. Mater. · 2018 · 30 · 180136210.1002/adma.201801362 ↗
9. Terstappen · Nat. Rev. Drug Discovery · 2021 · 20 · 36210.1038/s41573-021-00139-y ↗
10. Ruan · Adv. Sci. · 2021 · 8 · 200402510.1002/advs.202004025 ↗
11. Gao · Acta Pharm. Sin. B · 2016 · 6 · 26810.1016/j.apsb.2016.05.013 ↗
12. Zhang · Nat. Commun. · 2019 · 10 · 110.1038/s41467-018-07882-8 ↗
13. Tang · ACS Nano · 2019 · 13 · 1301510.1021/acsnano.9b05679 ↗
14. Ulbrich · Eur. J. Pharm. Biopharm. · 2009 · 71 · 25110.1016/j.ejpb.2008.08.021 ↗
15. Shirshova · J. Controlled Release · 2013 · 171 · 1710.1016/j.jconrel.2013.06.028 ↗
16. Liu · Adv. Mater. · 2021 · 210170110.1002/adma.202101701 ↗
17. Galstyan · Nat. Commun. · 2019 · 10 · 110.1038/s41467-019-11719-3 ↗
18. Liu · Adv. Mater. · 2021 · 33 · 210170110.1002/adma.202101701 ↗
19. Leroux · Nat. Nanotechnol. · 2007 · 2 · 67910.1038/nnano.2007.339 ↗
20. Chen · ACS Nano · 2019 · 13 · 720910.1021/acsnano.9b02773 ↗
21. Yang · Nanoscale · 2016 · 8 · 953710.1039/C5NR06658A ↗
22. Pang · ACS Nano · 2015 · 9 · 645010.1021/acsnano.5b02132 ↗
23. Costanzi · ACS Chem. Neurosci. · 2018 · 9 · 87310.1021/acschemneuro.8b00148 ↗
24. Kim · Chem. Rev. · 2011 · 111 · 534510.1021/cr100193y ↗
25. Suzuki · Lancet · 1995 · 345 · 98010.1016/S0140-6736(95)90726-2 ↗
26. Vale · Clin. Toxicol. · 2018 · 56 · 109310.1080/15563650.2018.1469759 ↗
27. Mercey · Chem. Commun. · 2011 · 47 · 529510.1039/c1cc10787a ↗
28. de Koning · Eur. J. Med. Chem. · 2018 · 157 · 15110.1016/j.ejmech.2018.08.016 ↗
29. Kono · Adv. Drug Delivery Rev. · 2001 · 53 · 30710.1016/S0169-409X(01)00204-6 ↗
30. Torchilin · Nat. Rev. Drug Discovery · 2005 · 4 · 14510.1038/nrd1632 ↗
31. van Helden · Toxicol. Appl. Pharmacol. · 1992 · 115 · 5010.1016/0041-008X(92)90366-Z ↗
32. Li · Acta Pharmacol. Sin. · 2019 · 40 · 144810.1038/s41401-019-0227-7 ↗
33. Huynh · Int. J. Pharm. · 2009 · 379 · 20110.1016/j.ijpharm.2009.04.026 ↗
34. Kassa · Toxicology · 1995 · 101 · 16710.1016/0300-483X(95)03091-S ↗
35. Quinn · Chem. Rev. · 1987 · 87 · 95510.1021/cr00081a005 ↗
36. Pashirova · J. Controlled Release · 2018 · 290 · 10210.1016/j.jconrel.2018.10.010 ↗
37. Buzyurova · Toxicology · 2020 · 444 · 15257810.1016/j.tox.2020.152578 ↗
38. Xu · Adv. Mater. · 2019 · 31 · 190072710.1002/adma.201900727 ↗
39. Yang · J. Controlled Release · 2016 · 243 · 16010.1016/j.jconrel.2016.10.008 ↗
40. Yang · Nat. Biomed. Eng. · 2020 · 4 · 110.1038/s41551-020-0584-z ↗
41. Wei · Sci. Adv. · 2021 · 7 · 637410.1126/sciadv.abe6374 ↗
42. Hartz · FASEB J. · 2019 · 33 · 1428110.1096/fj.201901369RR ↗
43. Grabb · J. Neurosurg. · 1995 · 82 · 105310.3171/jns.1995.82.6.1053 ↗
44. Xue · Nat. Nanotechnol. · 2017 · 12 · 69210.1038/nnano.2017.54 ↗
45. Xie · Acta Pharm. Sin. B · 2020 · 10 · 183510.1016/j.apsb.2020.09.005 ↗
46. Barnett · Gene Ther. · 2004 · 11 · 128310.1038/sj.gt.3302287 ↗
47. Pateman · Biomaterials · 2015 · 49 · 7710.1016/j.biomaterials.2015.01.055 ↗